Evidence map›Paper›PMID 39781529›Full record

ArticleInternational journal of medical sciences2025

The Red Cell Distribution Width to Albumin Ratio: A Novel Prognostic Indicator in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Maoqing Tan, Ruolan You, Danni Cai, Jin Wang, Wei Dai, Rong Yang, Dongliang Li, Huifang Huang

Abstract read
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maoqing TanCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Ruolan YouCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Danni CaiCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Jin WangCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Wei DaiCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Rong YangFollow-Up Center, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
Dongliang LiDepartment of Hepatobiliary Disease, Fuzong Clinical Medical College of Fujian Medical University (900TH Hospital of Joint Logistics Support Force), Fuzhou, Fujian, 350025, China.
Huifang HuangCentral Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularErythrocyte IndicesHepatitis B virusLiver NeoplasmsAdultAgedBiomarkers, TumorFemaleHepatitis BHumansMaleMiddle AgedPrognosisPropensity ScoreRetrospective StudiesRisk FactorsBiomarkers, TumorSerum AlbuminAlbuminHepatocellular carcinomaNet reclassification indexPrognosisRed cell distribution width

Identifiers

PMID39781529
PMCPMC11704691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.